Logo image of INNV

INNOVAGE HOLDING CORP (INNV) Stock Fundamental Analysis

NASDAQ:INNV - US45784A1043 - Common Stock

3.74 USD
+0.29 (+8.41%)
Last: 8/22/2025, 8:16:31 PM
3.74 USD
0 (0%)
After Hours: 8/22/2025, 8:16:31 PM
Fundamental Rating

3

Taking everything into account, INNV scores 3 out of 10 in our fundamental rating. INNV was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of INNV have multiple concerns. While showing a medium growth rate, INNV is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year INNV has reported negative net income.
In the past year INNV had a positive cash flow from operations.
In the past 5 years INNV reported 4 times negative net income.
In multiple years INNV reported negative operating cash flow during the last 5 years.
INNV Yearly Net Income VS EBIT VS OCF VS FCFINNV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

The Return On Assets of INNV (-5.82%) is worse than 70.19% of its industry peers.
The Return On Equity of INNV (-13.12%) is worse than 62.50% of its industry peers.
Industry RankSector Rank
ROA -5.82%
ROE -13.12%
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-2.82%
ROE(3y)-7.87%
ROE(5y)-2.14%
ROIC(3y)N/A
ROIC(5y)N/A
INNV Yearly ROA, ROE, ROICINNV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

INNV has a Gross Margin of 17.91%. This is in the lower half of the industry: INNV underperforms 62.50% of its industry peers.
In the last couple of years the Gross Margin of INNV has declined.
The Profit Margin and Operating Margin are not available for INNV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.12%
GM growth 5Y-6.16%
INNV Yearly Profit, Operating, Gross MarginsINNV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

3

2. Health

2.1 Basic Checks

INNV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INNV has more shares outstanding
The number of shares outstanding for INNV has been increased compared to 5 years ago.
The debt/assets ratio for INNV has been reduced compared to a year ago.
INNV Yearly Shares OutstandingINNV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
INNV Yearly Total Debt VS Total AssetsINNV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.05 indicates that INNV is not a great score, but indicates only limited risk for bankruptcy at the moment.
INNV has a Altman-Z score (2.05) which is comparable to the rest of the industry.
The Debt to FCF ratio of INNV is 4.81, which is a neutral value as it means it would take INNV, 4.81 years of fcf income to pay off all of its debts.
INNV has a better Debt to FCF ratio (4.81) than 71.15% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that INNV is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.04, INNV is doing good in the industry, outperforming 77.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.81
Altman-Z 2.05
ROIC/WACCN/A
WACC8.17%
INNV Yearly LT Debt VS Equity VS FCFINNV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.78 indicates that INNV may have some problems paying its short term obligations.
INNV has a worse Current ratio (0.78) than 82.69% of its industry peers.
A Quick Ratio of 0.78 indicates that INNV may have some problems paying its short term obligations.
With a Quick ratio value of 0.78, INNV is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
INNV Yearly Current Assets VS Current LiabilitesINNV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.27% over the past year.
The Revenue has grown by 12.18% in the past year. This is quite good.
INNV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.41% yearly.
EPS 1Y (TTM)27.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y6.2%
Revenue growth 5Y10.41%
Sales Q2Q%12.99%

3.2 Future

The Earnings Per Share is expected to grow by 44.54% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.43% on average over the next years. This is quite good.
EPS Next Y-77.28%
EPS Next 2Y53.76%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year12.69%
Revenue Next 2Y11.4%
Revenue Next 3Y11.43%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
INNV Yearly Revenue VS EstimatesINNV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
INNV Yearly EPS VS EstimatesINNV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -5 -10 -15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INNV. In the last year negative earnings were reported.
INNV is valuated quite expensively with a Price/Forward Earnings ratio of 73.33.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INNV is on the same level as its industry peers.
INNV is valuated expensively when we compare the Price/Forward Earnings ratio to 22.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 73.33
INNV Price Earnings VS Forward Price EarningsINNV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

INNV's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 31.58
EV/EBITDA N/A
INNV Per share dataINNV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as INNV's earnings are expected to grow with 44.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.76%
EPS Next 3Y44.54%

More info and screens

0

5. Dividend

5.1 Amount

INNV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INNOVAGE HOLDING CORP

NASDAQ:INNV (8/22/2025, 8:16:31 PM)

After market: 3.74 0 (0%)

3.74

+0.29 (+8.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)09-16 2025-09-16/amc
Inst Owners12.06%
Inst Owner Change-8.29%
Ins Owners1.98%
Ins Owner Change0.38%
Market Cap504.94M
Analysts48
Price Target5.78 (54.55%)
Short Float %1.57%
Short Ratio8.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-409.8%
Min EPS beat(2)-527.45%
Max EPS beat(2)-292.16%
EPS beat(4)1
Avg EPS beat(4)-190.35%
Min EPS beat(4)-527.45%
Max EPS beat(4)62.77%
EPS beat(8)2
Avg EPS beat(8)-120.73%
EPS beat(12)3
Avg EPS beat(12)-113.22%
EPS beat(16)4
Avg EPS beat(16)-99.95%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.1%
Revenue beat(4)1
Avg Revenue beat(4)-0.42%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)2.09%
Revenue beat(8)4
Avg Revenue beat(8)-0.15%
Revenue beat(12)4
Avg Revenue beat(12)-1.01%
Revenue beat(16)6
Avg Revenue beat(16)-0.45%
PT rev (1m)0%
PT rev (3m)-2.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.68%
EPS NY rev (1m)0%
EPS NY rev (3m)0.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 73.33
P/S 0.61
P/FCF 31.58
P/OCF 19.62
P/B 2.12
P/tB 5.5
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)0.05
Fwd EY1.36%
FCF(TTM)0.12
FCFY3.17%
OCF(TTM)0.19
OCFY5.1%
SpS6.16
BVpS1.76
TBVpS0.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.82%
ROE -13.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.91%
FCFM 1.92%
ROA(3y)-4.08%
ROA(5y)-2.82%
ROE(3y)-7.87%
ROE(5y)-2.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.12%
GM growth 5Y-6.16%
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 4.81
Debt/EBITDA N/A
Cap/Depr 45.45%
Cap/Sales 1.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z 2.05
F-Score6
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)155.97%
Cap/Depr(5y)146.35%
Cap/Sales(3y)3.3%
Cap/Sales(5y)3.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-77.28%
EPS Next 2Y53.76%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)12.18%
Revenue growth 3Y6.2%
Revenue growth 5Y10.41%
Sales Q2Q%12.99%
Revenue Next Year12.69%
Revenue Next 2Y11.4%
Revenue Next 3Y11.43%
Revenue Next 5YN/A
EBIT growth 1Y17.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year232.45%
EBIT Next 3Y71.94%
EBIT Next 5YN/A
FCF growth 1Y162.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.16%
OCF growth 3YN/A
OCF growth 5YN/A